ATE253357T1 - Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika - Google Patents
Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutikaInfo
- Publication number
- ATE253357T1 ATE253357T1 AT98939311T AT98939311T ATE253357T1 AT E253357 T1 ATE253357 T1 AT E253357T1 AT 98939311 T AT98939311 T AT 98939311T AT 98939311 T AT98939311 T AT 98939311T AT E253357 T1 ATE253357 T1 AT E253357T1
- Authority
- AT
- Austria
- Prior art keywords
- bergamottin
- oral bioavailability
- pharmaceuticals
- increasing
- compositions containing
- Prior art date
Links
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 title abstract 2
- DBMJZOMNXBSRED-OQLLNIDSSA-N bergomottin Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC/C=C(C)/CCC=C(C)C DBMJZOMNXBSRED-OQLLNIDSSA-N 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 235000015201 grapefruit juice Nutrition 0.000 abstract 2
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 abstract 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 210000000936 intestine Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5612997P | 1997-08-19 | 1997-08-19 | |
| PCT/US1998/016579 WO1999008676A1 (en) | 1997-08-19 | 1998-08-11 | Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE253357T1 true ATE253357T1 (de) | 2003-11-15 |
Family
ID=22002350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98939311T ATE253357T1 (de) | 1997-08-19 | 1998-08-11 | Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6509371B1 (de) |
| EP (1) | EP1007034B1 (de) |
| JP (1) | JP2001515035A (de) |
| KR (1) | KR100510809B1 (de) |
| AT (1) | ATE253357T1 (de) |
| AU (1) | AU747051B2 (de) |
| BR (1) | BR9812131A (de) |
| CA (1) | CA2291233C (de) |
| DE (1) | DE69819519T2 (de) |
| DK (1) | DK1007034T3 (de) |
| ES (1) | ES2209184T3 (de) |
| NZ (1) | NZ502668A (de) |
| PT (1) | PT1007034E (de) |
| WO (1) | WO1999008676A1 (de) |
| ZA (1) | ZA987436B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1014575A3 (fr) * | 2002-01-16 | 2004-01-13 | Chapelle Andre | Composition a base de 5,7 dmc et/ou de bergamottine. |
| US7169763B2 (en) * | 2002-02-22 | 2007-01-30 | Oliver Yoa-Pu Hu | Cytochrome P450 3A inhibitors and enhancers |
| EP1847266B1 (de) | 2005-01-21 | 2013-12-25 | ARKRAY, Inc. | Stoffwechselsyndrom verbesserndes agens und medizin, ergänzungsstoff, funktionelles lebensmittel und lebensmittelzusatz damit |
| JP4902964B2 (ja) * | 2005-03-30 | 2012-03-21 | 株式会社ファンケル | 薬物の代謝阻害剤とその使用 |
| UA116380C2 (uk) | 2013-05-30 | 2018-03-12 | Нанобіотікс | Посилення терапевтичної або профілактичної ефективності фармацевтичної сполуки |
| JP6836510B2 (ja) | 2014-11-25 | 2021-03-03 | キュラディグム・エスアエスＣｕｒａｄｉｇｍ Ｓａｓ | 少なくとも２つの異なるナノ粒子と医薬化合物とを組み合わせた医薬組成物、その調製及び使用 |
| HUE056175T2 (hu) * | 2014-11-25 | 2022-01-28 | Curadigm Sas | Gyógyászati készítmények, elõállításuk és alkalmazásaik |
| KR101729494B1 (ko) | 2015-06-29 | 2017-04-25 | 제주대학교 산학협력단 | 6,7-디하이드록시 베르가모틴을 함유한 화장료 조성물 |
| WO2024223797A1 (en) | 2023-04-28 | 2024-10-31 | Institut National de la Santé et de la Recherche Médicale | Use of cyp3a4 inhibitors for the treatment of hepatitis d virus (hdv) infections |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2996838B2 (ja) * | 1993-07-12 | 2000-01-11 | 株式会社ポッカコーポレーション | 抗菌剤 |
| US5567592A (en) | 1994-02-02 | 1996-10-22 | Regents Of The University Of California | Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal |
| US5716928A (en) | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| US5665386A (en) | 1995-06-07 | 1997-09-09 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| US5916566A (en) | 1995-06-07 | 1999-06-29 | Avmax, Inc. | Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds |
| WO1998017667A1 (en) * | 1996-10-18 | 1998-04-30 | Wayne State University | 6',7'-dihydroxybergamottin, a cytochrome p450 ihnibitor in grapefruit juice |
-
1998
- 1998-08-11 AT AT98939311T patent/ATE253357T1/de not_active IP Right Cessation
- 1998-08-11 US US09/486,117 patent/US6509371B1/en not_active Expired - Fee Related
- 1998-08-11 KR KR10-2000-7001649A patent/KR100510809B1/ko not_active Expired - Fee Related
- 1998-08-11 JP JP2000509416A patent/JP2001515035A/ja not_active Abandoned
- 1998-08-11 BR BR9812131-6A patent/BR9812131A/pt not_active Application Discontinuation
- 1998-08-11 DE DE69819519T patent/DE69819519T2/de not_active Expired - Fee Related
- 1998-08-11 NZ NZ502668A patent/NZ502668A/en unknown
- 1998-08-11 AU AU87770/98A patent/AU747051B2/en not_active Ceased
- 1998-08-11 WO PCT/US1998/016579 patent/WO1999008676A1/en not_active Ceased
- 1998-08-11 DK DK98939311T patent/DK1007034T3/da active
- 1998-08-11 PT PT98939311T patent/PT1007034E/pt unknown
- 1998-08-11 CA CA002291233A patent/CA2291233C/en not_active Expired - Fee Related
- 1998-08-11 ES ES98939311T patent/ES2209184T3/es not_active Expired - Lifetime
- 1998-08-11 EP EP98939311A patent/EP1007034B1/de not_active Expired - Lifetime
- 1998-08-18 ZA ZA987436A patent/ZA987436B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69819519T2 (de) | 2004-09-23 |
| DE69819519D1 (de) | 2003-12-11 |
| NZ502668A (en) | 2001-10-26 |
| PT1007034E (pt) | 2004-03-31 |
| KR20010023034A (ko) | 2001-03-26 |
| AU747051B2 (en) | 2002-05-09 |
| EP1007034A1 (de) | 2000-06-14 |
| AU8777098A (en) | 1999-03-08 |
| ES2209184T3 (es) | 2004-06-16 |
| DK1007034T3 (da) | 2004-03-22 |
| CA2291233C (en) | 2006-10-10 |
| CA2291233A1 (en) | 1999-02-25 |
| ZA987436B (en) | 1999-02-22 |
| US6509371B1 (en) | 2003-01-21 |
| JP2001515035A (ja) | 2001-09-18 |
| WO1999008676A1 (en) | 1999-02-25 |
| BR9812131A (pt) | 2000-07-18 |
| EP1007034B1 (de) | 2003-11-05 |
| KR100510809B1 (ko) | 2005-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE218341T1 (de) | Zwischenverbindungen von fortgeschrittenen glykosylierung-endprodukten und post-amadorische inhibitor | |
| IT1312377B1 (it) | Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche | |
| AU2002231544A1 (en) | Therapeutic uses of herbal compositions | |
| GEP20053602B (en) | Aripiprazole for Oral Administration | |
| HUP0201214A3 (en) | Inhibitors of impdh enzyme, pharmaceutical compositions containing them and their use | |
| AU6434600A (en) | Biphenyl derivatives, production thereof and use as medicines | |
| BR0108564A (pt) | Preparações cosméticas contendo extratos vegetais | |
| IL164217A0 (en) | Pharmaceutical compositions containing water-soluble propofol and methods of administering same | |
| EA200401515A1 (ru) | Новые фармацевтические композиции, содержащие флибансерин в полиморфной модификации а | |
| FR2827774B1 (fr) | Preparations pharmaceutiques et/ou dietetiques contenant un extrait vegetal titre en composes actifs et des micro-organismes probiotiques | |
| DE69819519D1 (de) | Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika | |
| AU2003246567A1 (en) | Administration form for the oral administration of active substances, vitamins, and/or nutrients | |
| MY130792A (en) | 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES | |
| IL122195A0 (en) | Diaromatic propynyl or dienyl compounds | |
| NO992998L (no) | Nye analoger av camptotecin, anvendelse som medikamenter og farmasöytiske blandinger som inneholder disse | |
| HUP0203449A2 (hu) | L-karnitin-számazékokat és ginkgo biloba kivonatot tartalmazó készítmény keringési rendellenességek megelőzésére és/vagy kezelésére | |
| AU5634500A (en) | Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis | |
| HK1045987A1 (zh) | 3-氨基-2-苄基-1-苯基-丙烷衍生物 | |
| RU94031068A (ru) | Биологически активная добавка для косметических средств | |
| HUP9902421A2 (hu) | Nyálkahártya-viszkozitást optimalizáló és bélfunkciót stimuláló hatású készítmények | |
| NZ512525A (en) | Skin whitening compositions for oral administration comprising a solvent extract from the plant of the genus Rosaceae Pyracantha | |
| WO2002070069A3 (fr) | Utilisation d'un ou plusieurs shogaol(s) en tant qu'aphrodisiaque | |
| EP1491192A4 (de) | Die biologische wirkung fördernde zusammensetzungen mit isoflavon-agklykon aus sojabohnenkeimen | |
| ATE301469T1 (de) | Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase | |
| ATE404519T1 (de) | Hyperforinderivate, ihre verwendung sowie diese enthaltende zubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1007034 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |